Publications by authors named "Showkat Hamid"

Claim this Profile
I
IFNγ-driven skewing towards Th1 over Th17 differentiationunderlies CRSand neutropenia in CAR-T therapy.
Payal Goala, Yongliang Zhang, Nolan J Beatty, Allan Pavy, Shannon L McSain, Showkat Hamid

J Clin Invest· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicities.
Payal Goala, Yongliang Zhang, Cooper Sailer, Shannon McSain, Muhammad Junaid Tariq, Showkat Hamid

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers.
Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, Jorge Florindez, Na Hyun Kim, Showkat Hamid

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma.
Marco Davila, Sae Bom Lee, Yun Pyo Kang, Justin Boucher, Jay Mandula, Showkat Hamid

Res Sq· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center.
Michelle Walter, Eric Hansen, Showkat Hamid, Desi Carozza, Gary Mann

J Pain Symptom Manage· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis